Literature DB >> 8018497

Etiology of sustained hypertension in children in the southwestern United States.

M Y Arar1, R J Hogg, B S Arant, M G Seikaly.   

Abstract

We reviewed the records of 132 children with persistent hypertension who were evaluated by our pediatric nephrology services between 1987 and 1991. Eighty-nine (67%) of these children were found to have renal or renovascular disease, 30 (23%) had primary hypertension and 13 (10%) had a non-renal cause for their hypertension. Glomerulonephritis (n = 37) and reflux nephropathy (n = 26) were the most frequent renal disorders identified. Renal artery thrombosis was the most common cause of hypertension in the neonatal period (in 6 of 12 neonates, 50%) whereas cystic kidney disease was the most common cause of hypertension in the 1st year of life (in 9 of 30 infants, 30%). The prevalence of primary hypertension increased with age; this diagnosis was made in 16 of 46 (35%) hypertensive patients between 12 and 18 years of age and, more surprisingly, in 8 of 27 (30%) children between 7 and 11 years of age. These data confirm that secondary hypertension is the most common cause of hypertension in children but suggest that primary hypertension is more prevalent than previously recognized in patients between 7 and 18 years of age.

Entities:  

Mesh:

Year:  1994        PMID: 8018497     DOI: 10.1007/bf00865475

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  Analysis of 100 children with severe and persistent hypertension.

Authors:  D G Gill; B Mendes de Costa; J S Cameron; M C Joseph; C S Ogg; C Chantler
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

2.  Renal artery embolism causing neonatal hypertension: a complication of umbilical artery catheterization.

Authors:  K T Ford; S K Teplick; R E Clark
Journal:  Radiology       Date:  1974-10       Impact factor: 11.105

3.  Coarse pyelonephritic scarring or 'atrophic pyelonephritis'.

Authors:  C J Hodson
Journal:  Proc R Soc Med       Date:  1965-10

Review 4.  The epidemiology of hypertension in children.

Authors:  M de Swiet
Journal:  Br Med Bull       Date:  1986-04       Impact factor: 4.291

5.  Neonatal hypertension.

Authors:  R D Adelman
Journal:  Pediatr Clin North Am       Date:  1978-02       Impact factor: 3.278

6.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

7.  Hypertension screening in schools: results of the Dallas study.

Authors:  D E Fixler; W P Laird; V Fitzgerald; S Stead; R Adams
Journal:  Pediatrics       Date:  1979-01       Impact factor: 7.124

8.  Long-term follow-up of neonatal renovascular hypertension.

Authors:  R D Adelman
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

9.  A single pediatric center experience with 1025 children with hypertension.

Authors:  T Wyszyńska; E Cichocka; A Wieteska-Klimczak; K Jobs; P Januszewicz
Journal:  Acta Paediatr       Date:  1992-03       Impact factor: 2.299

10.  Normal blood pressure and the evaluation of sustained blood pressure elevation in childhood: the Muscatine study.

Authors:  L K Rames; W R Clarke; W E Connor; M A Reiter; R M Lauer
Journal:  Pediatrics       Date:  1978-02       Impact factor: 7.124

View more
  31 in total

Review 1.  Hypertension in the newborn baby.

Authors:  M Watkinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

2.  High prevalence of elevated blood pressure among children with neurofibromatosis type 1.

Authors:  Tom Dubov; Hagit Toledano-Alhadef; Gil Chernin; Shlomi Constantini; Roxana Cleper; Shay Ben-Shachar
Journal:  Pediatr Nephrol       Date:  2015-08-28       Impact factor: 3.714

3.  Neonatal renovascular hypertension due to prenatal traumatic retroperitoneal hematoma.

Authors:  Bradley P Dixon; Prasad Devarajan; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2005-02-15       Impact factor: 3.714

4.  Essential hypertension vs. secondary hypertension among children.

Authors:  Monesha Gupta-Malhotra; Ashish Banker; Sanjay Shete; Syed Sharukh Hashmi; John E Tyson; Michelle S Barratt; Jacqueline T Hecht; Diane M Milewicz; Eric Boerwinkle
Journal:  Am J Hypertens       Date:  2014-05-18       Impact factor: 2.689

Review 5.  Autonomic nervous system dysregulation in pediatric hypertension.

Authors:  Janusz Feber; Marcel Ruzicka; Pavel Geier; Mieczyslaw Litwin
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

6.  A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension.

Authors:  Ronald J Hogg; Angela Delucchi; Graciela Sakihara; Thomas G Wells; Frank Tenney; Donald L Batisky; Jeffrey L Blumer; Beth A Vogt; Man-Wai Lo; Elizabeth Hand; Deborah Panebianco; Ronda Rippley; Wayne Shaw; Shahnaz Shahinfar
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

7.  Reflux nephropathy and hypertension: correlation with the progression of renal damage.

Authors:  Giuliana Lama; Michele Adolfo Tedesco; Luisa Graziano; Elvira Calabrese; Carolina Grassia; Francesco Natale; Giuseppe Pacileo; Pier Francesco Rambaldi; Maria Esposito-Salsano
Journal:  Pediatr Nephrol       Date:  2003-02-26       Impact factor: 3.714

8.  Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up.

Authors:  Wael A Seliem; Michael C Falk; Bruce Shadbolt; Alison L Kent
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

9.  A young patient with a family history of hypertension.

Authors:  Aldo J Peixoto
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

10.  Dimercaptosuccinic acid (DMSA) renal scan in the evaluation of hypertension in children.

Authors:  Maheen Ahmed; Daniel Eggleston; Gaurav Kapur; Amrish Jain; Rudolph P Valentini; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2007-11-20       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.